(Q80800365)

English

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis

scientific article published on 20 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

clear cell carcinoma

1 reference

based on heuristic

inferred from title

11

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

object named as

Nobuo Yaegashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

object named as

Toru Sugiyama

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

9

object named as

Junzo Kigawa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yasuhiro Udagawa

7

object named as

Yasuhiro Udagawa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Satoshi Takeuchi

10

object named as

Satoshi Takeuchi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Masashi Takano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mitsuaki Suzuki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hiroshi Tsuda

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Satoru Sagae

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kazuo Kuzuya

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Takuya Moriya

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yoshihiro Kikuchi

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

20 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

256-260

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

https://scigraph.springernature.com/pub.10.1007/s10147-007-0670-1

0 references

Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CPT-11 in combination with other anti-cancer agents in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active metabolite of CPT-11, for cisplatin-resistant HeLa cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701003

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-007-0670-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701003%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80800365&oldid=1777426987"